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Obesity and the kidney: Why is 
the kidney at risk?
NK Hollenberg1,2
Two recent studies may help to account for the increase in risk of 
renal injury associated with obesity. One study pointed to a role 
for renin-system activation. In the other study, the pattern of renal 
hemodynamics was compatible with a renin mechanism.
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In this issue of Kidney International, 
Krikken et al.1 describe an interesting 
set of relationships between body mass 
index (BMI), salt intake, glomerular 
filtration rate, and filtration fraction 
in healthy young men. Ten years ago, 
these relationships would probably 
have been of interest to only a small 
number of people, those fascinated by 
details of how the kidney works. Today, 
the interest will be substantially greater. 
Why? About ten years ago, Ribstein et al. 
described the eff ects of overweight and 
hypertension on the kidney.2 Over the 
ensuing several years, there has been a 
rapid accumulation of information to 
suggest that obesity negatively infl uences 
the kidney, placing it at increased risk 
of injury and end-stage disease.3–8 Why 
should that be?
Krikken et al.1 point out in their Dis-
cussion, quite correctly, that this study 
was not designed to assess mechanisms. 
Th ey cite a number of possible expla-
nations, including a recently published 
work from our laboratory on the renin 
system and obesity in healthy indi-
viduals.9 Both studies focus on healthy 
young people and measure renal hemo-
dynamics as their end point, and they 
are almost certainly addressing the same 
issue. Th ey diff er in several ways. In our 
study,9 the primary end point was the 
infl uence of captopril or an angiotensin 
receptor blocker on renal perfusion. As 
the response to captopril and to the angio-
tensin receptor blocker was essentially 
identical, we can assume that the mea-
sure provides an index of the contribu-
tion of the renin system to renovascular 
tone. Th e study was positive: increasing 
BMI was associated with an increase in 
renovascular response to interruption of 
the renin system.
Th e substudies also diff er in the fre-
quency of obesity: Both the study in Hol-
land1 and the study in the United States9 
recruited subjects without reference to 
their BMI. Only two of the 95 Dutch had 
a BMI over 30.1 Twenty-two of 100 had a 
BMI over 30 in the United States.9
The relationship was not linear: 
indeed, for the fi rst time in my scientifi c 
career, a quadratic function provided 
a best fi t.9 Th e vasodilator response to 
angiotensin-converting enzyme inhibi-
tion began to increase at a BMI of 25 but 
became substantially greater at a BMI 
exceeding 30 (Figure 1).
These two studies raise important 
questions. One involves the mechanism 
for renin-system activation. Th ere are 
a number of candidates. The second, 
probably more important, is what we 
should do about it. As so many of our 
patients at risk of end-stage renal dis-
ease are obese, it is reasonable to won-
der whether dealing with the obesity will 
improve the natural history. Th ere is an 
anecdotal literature to indicate that bari-
atric surgery, when eff ective in reducing 
body mass, can reverse hypertension 
and reverse proteinuria in patients with 
diabetes and nephropathy. Probably, we 
ought to be discussing what that means 
for our patients.
REFERENCES
1. Krikken JA, Lely AT, Bakker SJL, Navis G. The 
effect of a shift in sodium intake on renal 
hemodynamics is determined by body mass 
index in healthy young men. Kidney Int 2007; 71: 
260–265. 
2. Ribstein J, du Cailar G, Mimran A. Combined 
renal effects of overweight and hypertension. 
Hypertension 1995; 26: 610–615.
3. Praga M, Hernandez E, Herrero JC et al. Influence 
of obesity on the appearance of proteinuria and 
1Department of Medicine, Harvard Medical School 
and Brigham and Women’s Hospital, Boston, 
Massachusetts, USA; and 2Department of Radiology, 
Harvard Medical School and Brigham and Women’s 
Hospital, Boston, Massachusetts, USA.
Correspondence: NK Hollenberg, Brigham and 
Women’s Hospital, 75 Francis Street, Boston, 
Massachusetts 02115, USA. 
E-mail: djpagecapo@rics.bwh.harvard.edu
Figure 1| Relation between body mass index (BMI) and the renal plasma flow (RPF) response 
to captopril in healthy volunteers. Note that the data were best fit by a quadratic. The RPF 
response began to increase in those who were overweight (BMI 25–30 kg/m2) and then rose much 
more quickly in those who were obese (BMI > 30 kg/m2). (Reprinted from ref. 9.)
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Is it the low-protein diet or simply 
the salt restriction?
MR Weir1
Dietary factors, such as salt and protein intake, may play an 
important role in the progression of kidney disease. Consequently, 
dietary manipulations of these constituents are of interest both in 
experimental models of kidney disease and in clinical trials with 
patients with chronic kidney disease to assess whether modification 
of these exposures will result in a stabilization of disease progression.
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Chronic kidney disease (CKD) is a more 
common clinical problem that once 
thought and is frequently associated 
with substantial cardiovascular morbid-
ity and mortality. It is well recognized 
that better control of blood pressure is 
important in mitigating the progression 
of CKD. In addition, pharmacological 
manipulation of the renin–angiotensin 
system plays an important role as part 
of an eff ective blood pressure-lowering 
strategy in reducing the rate of progres-
sion of kidney disease. It is also recog-
nized that dietary factors may also be 
important in the rate of progression of 
kidney disease.1 Both dietary protein 
and salt have been implicated as targets 
for manipulation to limit progression of 
kidney disease.
When the Modification of Diet in 
Renal Disease study was completed 
more than a decade ago, it was assumed 
that blood pressure, and not intensive 
dietary protein restriction, was the criti-
cal factor in limiting the progression of 
kidney disease.2 However, it is impor-
tant to note that in the Modifi cation of 
Diet in Renal Disease study the major-
ity of patients received angiotensin-
converting enzyme  inhibitors and 
calcium channel blockers, achieved 
the respective target blood pressure 
goals, and had intensive dietary edu-
cation to achieve a daily salt intake of 
approximately 1 g. It is quite likely that 
improved blood pressure control, angi-
otensin-converting enzyme inhibition, 
and dietary salt restriction mitigated 
the potential benefi ts of a very-low-pro-
tein diet in delaying the progression of 
kidney disease. Moreover, the trial design 
did not use a washout period to remove 
from the analysis the initial hemody-
namic decrease of glomerular fi ltration 
rate in response to the reduction of pro-
tein intake. It is also important to note 
that reduction in dietary protein can 
reduce glomerular fi ltration rate, hyper-
fi ltration, and proteinuria, which could 
be helpful in mitigating the progression 
of kidney disease. I suspect that more 
eff ort has not been focused on dietary 
protein restriction because of concerns 
about impairing nutrition, which is par-
ticularly important in patients with more 
advanced kidney disease, and problems 
of cost and compliance with specialized 
lower-protein diets.
In an interesting paper, Bellizzi et al.3 
(this issue) report their evaluation of 
a very-low-protein diet supplemented 
with ketoanalogs in patients with stage 4 
and stage 5 kidney disease. Th is study 
is reminiscent of the Modifi cation of 
Diet in Renal Disease study and incor-
porated the same types of patients with 
more advanced forms of kidney disease. 
Th e authors clearly demonstrate that 
those patients on the very-low-protein 
diet achieved a statistically signifi cant 
reduction of blood pressure despite 
concurrent reduction in antihyperten-
sive medication. Moreover, they dem-
onstrate that urine urea correlated with 
reduced urinary sodium excretion and 
that blood pressure reduction was inde-
pendently related to urinary sodium 
excretion and the very-low-protein diet 
restriction, but not the level of protein 
intake. Th eir working hypothesis with 
these results raised the question of why 
the very-low-protein diet was eff ective 
in reducing the blood pressure. Was it 
simply reduced dietary sodium intake, 
or the type of vegetable proteins in the 
very-low-protein diet, or the ketoanalog 
supplementation, which could provide 
a vasodilator eff ect of branched-chain 
essential amino acids? Although the 
authors are fair in providing a bal-
anced perspective in this regard, I fi nd 
it quite likely that the majority of the 
effects are related simply to reduced 
dietary salt exposure. The authors 
importantly noted that there was a cor-
relation between decreased fractional 
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